Phenominer Database Results (14 hits)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
F344.OLETF-(D14Rat23-D14Rat12)/Tj mesenteric fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. mesenteric fat pad mass male 218 days 11 8.8 g 0.4 1.33 post excision weight measurement 0 12794 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj retroperitoneal fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. retroperitoneal fat pad mass male 218 days 11 10.5 g 0.4 1.33 post excision weight measurement 0 12795 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum adiponectin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood adiponectin amount male 211 days 11 3.02 ng/ml 0.15 0.5 enzyme linked immunosorbent assay 0.0 0 ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67481 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum leptin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood leptin amount male 211 days 11 6.28 ng/ml 0.51 1.69 enzyme linked immunosorbent assay 0.0 oral glucose 7 days ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67485 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj mesenteric fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. mesenteric fat pad mass male 218 days 11 2.06 % 0.09 0.3 post excision weight measurement 0.0 0 67469 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj epididymal fat pad weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. epididymal fat pad mass male 218 days 11 10.6 g 0.3 0.99 post excision weight measurement 0 12796 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj retroperitoneal fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. retroperitoneal fat pad mass male 218 days 11 2.47 % 0.09 0.3 post excision weight measurement 0.0 0 67473 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum insulin level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood insulin amount male 211 days 11 0.0 mg/dl 0.0 0.0 oral glucose tolerance test 0.0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 67477 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj epididymal fat pad weight to body weight ratio specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. epididymal fat pad mass male 218 days 11 2.49 % 0.06 0.2 post excision weight measurement 0.0 0 67493 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum triglyceride level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood triglyceride amount male 218 days 11 113.5 mg/dl 4.81 15.95 serum triglyceride analysis 0 0 Wako Pure Chemicals, Tokyo, Japan 13194 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum total cholesterol level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood cholesterol amount male 218 days 11 72.7 mg/dl 2.13 7.06 serum total cholesterol measurement test 0.0 0 Wako Pure Chemicals, Tokyo, Japan 12793 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 11 425.3 g 5.3 17.58 body weighing method 0.0 oral glucose 0 min 12797 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj serum free fatty acids level specific pathogen-free condition (for 210 days) then fasting (for 1 days) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood free fatty acid amount male 218 days 11 0.66 mmol/l 0.05 0.16 serum free fatty acid analysis 0.0 0 Wako Pure Chemicals, Tokyo, Japan 67497 311
F344.OLETF-(D14Rat23-D14Rat12)/Tj blood glucose level specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. blood glucose amount male 211 days 11 82.5 mg/dl 3.5 11.61 oral glucose tolerance test 0 oral glucose 0 min ADVANTAGE II glucose monitor (Roche Diagnostics, Indianapolis, IN) 12792 311